about
Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patientsXanthogranulomatous cholecystitis: a European and global perspectiveIndex admission laparoscopic cholecystectomy for patients with acute biliary symptoms: results from a specialist centre.Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samplesEvolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusionA cost effective analysis of a laparoscopic versus an open left lateral sectionectomy in a liver transplant unitInferior vena cava resection with hepatectomy: challenging but justified.Anaesthetic and pharmacological techniques to decrease blood loss in liver surgery: a systematic review.Management of blunt liver trauma in a tertiary referral centre.Role of quantification of hepatic steatosis and future remnant volume in predicting hepatic dysfunction and complications after liver resection for colorectal metastases: a pilot studyNon-operative management of pyogenic liver abscess.Treatment and surveillance of polypoid lesions of the gallbladder in the United Kingdom.Mirizzi's syndrome--results from a large western experience.The role of (99m)technetium-labelled hepato imino diacetic acid (HIDA) scan in the management of biliary painIndication for treatment and long-term outcome of focal nodular hyperplasiaC-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases.Prognostic influence of multiple hepatic metastases from colorectal cancer.A simple prophylaxis regimen for MRSA: its impact on the incidence of infection in patients undergoing liver resectionCytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cellsRepeat liver resection after a hepatic or extended hepatic trisectionectomy for colorectal liver metastasis.Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer.Viral warfare! Front-line defence and arming the immune system against cancer using oncolytic vaccinia and other viruses.Relationship between primary colorectal tumour and location of colorectal liver metastases.Hepatocellular carcinoma in variegate porphyria: a case report and literature review.Biliary and portal vein strictures following treatment of Hodgkin's lymphoma.Outcome after liver resection in patients presenting with simultaneous hepatopulmonary colorectal metastases.Management of gallbladder dyskinesia: patient outcomes following positive ⁹⁹mtechnetium (Tc)-labelled hepatic iminodiacetic acid (HIDA) scintigraphy with cholecystokinin (CCK) provocation and laparoscopic cholecystectomy.A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection.Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.Measurement of red blood cell eicosapentaenoic acid (EPA) levels in a randomised trial of EPA in patients with colorectal cancer liver metastases.Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule.Immunohistochemical measurement of endothelial cell apoptosis and proliferation in formalin-fixed, paraffin-embedded human cancer tissue.Impact of parenchymal preserving surgery on survival and recurrence after liver resection for colorectal liver metastasis.Outcome following repeat liver resection for colorectal liver metastases.Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer.Redefining major hepatic resection for colorectal liver metastases: Analysis of 1111 liver resections.Clinical outcomes of left hepatic trisectionectomy for hepatobiliary malignancy.Regional differences in prostaglandin E₂ metabolism in human colorectal cancer liver metastases.Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo.Early experience with stenting for iliac occlusive disease.
P50
Q24617027-E73A01AB-887E-48DD-AD7C-A7BB277C7C53Q33558963-F492167C-27E6-47EC-95C8-DCAAE828AA19Q33865039-6FA18E81-69D8-4037-BA29-98591DEF1FC5Q34763999-A115024F-F9B2-4D91-A6FA-E233CBC91FF9Q35097616-F38AB592-33C3-45D8-8168-4B11B624A761Q35202206-A2E4EFD7-E865-4D84-986F-949146539696Q35613924-33C01D5C-7CCC-4B1F-AA0C-6911EE0D22C1Q35663399-B5DEC416-D635-4FE5-9707-320B1C393E0EQ35678502-CB3C014D-A709-4994-B12B-7B583BEA83EBQ36020112-C9B97C11-5666-4D2E-85A0-14F5C67EC218Q36063159-AA11769C-4A18-4E94-B527-28C38FB0AFB2Q36063334-CE172BE3-268E-4957-9746-3803DB94CD19Q36063408-EA83E4B5-1FDE-433B-B265-F3D948D78ADBQ36116989-5EBE9647-8469-49B2-BBAD-648229BF1F97Q36426933-0163E28A-4D64-4B45-8FA1-B0C0BE3E1FFDQ36609762-488FD341-BD7C-4FEC-ABE2-FE1BE9932BA7Q36649966-D24C365C-7283-477D-BE82-F3827A707008Q37363367-858C8C1E-2D5A-4149-B401-72458B7F5F6AQ37477574-E3BA2251-6ABB-4B3B-B403-591B0BEC6E87Q37623494-AC77DEFF-8634-4159-B57D-62BC5389BCE6Q37864884-2771E079-7146-4B77-901E-6A6BE625EA0FQ38185772-4A83664C-4CC4-4841-853A-61B30662DB4CQ38231527-96870223-814B-4040-905E-868864A1C7C4Q38258722-C741571B-DB8A-42FC-970A-96716F6BD46EQ38273620-33E25EBC-7A42-4EC6-B7AD-4C438285331FQ38295923-62A898AD-41B0-48EC-BF38-033C8FD7359AQ38318489-9FB3C6A0-6DED-4A19-9F58-5D51173BCB03Q38364021-6867BE5D-6A5D-4315-B4B4-5561251A302CQ38437209-E797BC6E-D5F1-4AAF-A3AC-2BD82ECA4290Q38787649-092F572E-2EBB-4A50-AC19-9C3B8ECB2FA2Q39215344-A9B04D92-6176-40D4-97BB-706222412104Q39775036-9D59B448-3390-428C-BB61-6F4244449691Q39824770-69728BA0-7FD7-4FAB-A068-820001F65CBFQ40247983-9623DE79-E161-442D-9AF1-8F5985D8697DQ40429665-A4EBB121-FD74-4428-B267-CF0B934F5356Q40549366-D48F2D0F-C8B9-4788-949E-69D0A9D78592Q41028368-3C5A904B-308C-4D35-9020-7FBBEBFBF299Q41081492-2FE1ACD5-ED71-44B4-9048-3ED1AAD884DAQ41621228-D64F81A5-0043-41E0-9A7B-F884B9E465B7Q41742911-1F99EC25-292F-443B-8EEE-A2E6E626A552
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giles J. Toogood
@ast
Giles J. Toogood
@en
Giles J. Toogood
@es
Giles J. Toogood
@nl
Giles J. Toogood
@sl
type
label
Giles J. Toogood
@ast
Giles J. Toogood
@en
Giles J. Toogood
@es
Giles J. Toogood
@nl
Giles J. Toogood
@sl
altLabel
Giles Toogood
@en
prefLabel
Giles J. Toogood
@ast
Giles J. Toogood
@en
Giles J. Toogood
@es
Giles J. Toogood
@nl
Giles J. Toogood
@sl
P106
P1153
6701876763
P21
P31
P496
0000-0003-4535-6249